Existence of deamidated αB-crystallin fragments in normal cataractous human lenses

Molecular Vision

Volumn 9, Issue , 2003, Pages 110-118

  Srivastava, Om P ^a   Srivastava, Kiran ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CRYSTALLIN; BETA CRYSTALLIN; TRICHLOROACETIC ACID; ASPARAGINE; PEPTIDE; PEPTIDE FRAGMENT;

ADULT; AGED; AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CATARACT; CENTRIFUGATION; CHEMICAL PROCEDURES; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DEAMINATION; FREEZE DRYING; HUMAN; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR WEIGHT; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN PROCESSING; SEQUENCE ANALYSIS; SOLUBILIZATION; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING; AMINO ACID SEQUENCE; LENS; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS;

AGED; AGED, 80 AND OVER; ALPHA-CRYSTALLIN B CHAIN; AMINO ACID SEQUENCE; ASPARAGINE; BLOTTING, WESTERN; CATARACT; DEAMINATION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; LENS, CRYSTALLINE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; PEPTIDE FRAGMENTS; PEPTIDES; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 0345825772     PISSN: 10900535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Harding J. Cataract: biochemistry, epidemiology, and pharmacology. New York: Chapman & Hall; 1991.
2. Robinson AB, Rudd CJ. Deamidation of glutaminyl and asparaginyl residues in peptides and proteins. Curr Top Cell Regul 1974; 8:274-95.
3. Robinson NE. Protein deamidation. Proc Natl Acad Sci U S A 2002; 99:5283-8.
4. Kim E, Lowenson JD, MacLaren DC, Clarke S, Young SG. Deficiency of protein-repair enzyme results in accumulation of altered proteins, retardation of growth and fatal seizures in mice. Proc Natl Acad Sci U S A 1997; 94:6132-7.
5. Liu DT. Deamidation: a source of microheterogeneity in pharmaceutical proteins. Trends Biotechnol 1992; 10:364-9.
6. Robinson NE, Robinson AB. Molecular clocks. Proc Natl Acad Sci U S A 2001; 98:944-9.
7. Flatmark T, Sletten K. Multiple forms of cytochrome c in the rat. Precursor-product relationship between the main component Cy I and minor components Cy II and Cy 3 in vivo. J Biol Chem 1968; 243:1623-9.
8. Robinson AB, McKerrow JH, Legaz M. Sequence dependent deamidation rates for model peptides of cytochrome C. Int J Pept Protein Res 1974; 6:31-5.
9. Midelfort CF, Mehler AH. Deamidation in vivo of an asparagine residue of rabbit muscle aldolase. Proc Natl Acad Sci U S A 1972; 69:1816-9.
10. Lindner H, Sarg B, Hoertnagl B, Helliger W. The microheterogeneity of the mammalian H1(0) histone. Evidence for an age-dependent deamidation. J Biol Chem 1998; 273:1324-30.
11. Inaba M, Gupta KC, Kuwabara M, Takahashi T, Benz EJ Jr, Maede Y. Deamidation of human erythrocyte protein 4.1: possible role in aging. Blood 1992; 79:3355-61.
12. Solstad T, Flatmark T. Microheterogeneity of recombinant human phenylalanine hydroxylase as a result of nonenzymatic deamidations of labile amide containing amino acids. Effect on catalytic and stability properties. Eur J Biochem 2000; 267:6302-10.
13. Sun AQ, Yuksel KU, Gracy RW. Terminal marking of triosephosphate isomerase: consequences of deamidation. Arch Biochem Biophys 1995; 322:361-8.
14. Capasso S, Salvadori S. Effect of three-dimensional structure on deamidation reaction of ribonuclease A. J Pept Res 1999; 54:377-82.
15. Takemoto L, Boyle D. Increased deamidation of asparagine during human senile cataractogenesis. Mol Vis 2000; 6:164-8 .
16. Robinson NE, Robinson AB. Prediction of protein deamidation rates from primary and three-dimensional structure. Proc Natl Acad Sci U S A 2001; 98:4367-72.
17. Van Kleef SM, Willems-Thijssen W, Hoenders HJ. Intracellular degradation and deamidation of alpha-crystallin subunits. Eur J Biochem 1976; 66:477-83.
18. Groenen PJ, van Dongen MJ, Voorter CE, Bloemendal H, de Jong WW. Age-dependent deamidation of alpha B-crystallin. FEBS Lett 1993; 322:69-72.
19. Miesbauer LR, Zhou X, Yang Z, Yang Z, Sun Y, Smith DL, Smith JB. Post-translational modifications of water-soluble human lens crystallins from young adults. J Biol Chem 1994; 269:12494-502.
20. Lund AL, Smith JB, Smith DL. Modifications of the water-insoluble human lens alpha-crystallins. Exp Eye Res 1996; 63:661-72.
21. Takemoto L, Boyle D. Specific glutamine and asparagine residues of gamma-S crystallin are resistant to in vivo deamidation. J Biol Chem 2000; 275:26109-12.
22. Takemoto L, Boyle D. Deamidation of specific glutamine residues from alpha-A crystallin during aging of the human lens. Biochemistry 1998; 37:13681-5.
23. Cacia J, Quan CP, Vasser M, Sliwkowski MB, Frenz J. Protein sorting by high-performance liquid chromatography. I. Biomimetic interaction chromatography of recombinant human deoxyribonuclease I on polyionic stationary phases. J Chromatogr 1993; 634:229-39.
24. Teshima G, Porter J, Yim K, Ling V, Guzzetta A. Deamidation of soluble CD4 at asparagine-52 results in reduced binding capacity for HIV-1 envelop glycoprotein gp120. Biochemistry 1991; 30:3916-22.
25. Becker GW, Tackitt PM, Bromer WW, Lefeber DS, Riggin RM. Isolation and characterization of sulfoxide and desamido derivative of biosynthetic human growth hormone. Biotechnol Appl Biochem 1988; 10:326-37.
26. Wright T. Amino acid abundance and sequence data: clues to biological significance of non-enzymatic asparagine and glutamine deamidation in proteins. In: Aswad DW, editor. Deamidation and isoaspartate formation in peptides and proteins. Boca Raton: CRC Press; 1995. p. 229-251.
27. Srivastava OP, McEntire JE, Srivastava K. Identification of a 9 kDa gamma-crystallin fragment in human lenses. Exp Eye Res 1992; 54:893-90.
28. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227:680-5.
29. Towbin H, Stahelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 1979; 79:4350-4.
30. Srivastava OP, Srivastava K, Silney C. Covalent modification at the C-terminal end of a 9 kDa gamma D-crystallin fragment in human lenses. Exp Eye Res 1994; 58:595-603.
31. Laskowski M Jr, Kato I. Protein inhibitors of proteinases. Annu Rev Biochem 1980; 49:593-626.
32. Srivastava OP, Ortwerth BJ. Purification and properties of a protein from bovine lens which inhibits trypsin and two endogenous lens proteinases. Exp Eye Res 1983; 36:363-79.
33. Srivastava OP, Ortwerth BJ. Age-related and distributional changes in the trypsin inhibitor activity of bovine lens. Exp Eye Res 1983; 36:695-709.
34. Cook LA, Schey KL, Wilcox MD, Dingus J, Hildebrandt JD. Heterogeneous processing of a G protein gamma-subunit at a site critical for protein and membrane interactions. Biochemistry 1998; 37:12280-6.
35. Truscott RJ, Chen YC, Shaw DC. Evidence for the participation of alpha B-crystallin in human age-related nuclear cataract. Int J Biol Macromol 1998; 22:321-30.
36. Lampi KJ, Oxford JT, Bachinger HP, Shearer TR, David LL, Kapfer DM. Deamidation of human beta B1 alters the elongated structure of the dimer. Exp Eye Res 2001; 72:279-88.
37. van Kleef FS, Nijzink-Maas MJ, Hoenders HJ. Intracellular degradation of alpha-crystallin. Fractionation and characterization of degraded alpha A-chains. Eur J Biochem 1974; 48:563-70.
38. Takemoto L, Emmons T, Horwitz J. The C-terminal region of alpha-crystallin: involvement in protection against heat-induced denaturation. Biochem J 1993; 294:435-8.